Allergopharma
Germany - ReinbekPharmaceutical
Focus: Allergopharma is a German-based specialty pharmaceutical company focused on specific immunotherapy (allergen-based treatments) for respiratory allergies including pollen, house dust mite, and venom allergies. The company operates as a niche player in the immunotherapy space with a concentrated portfolio of allergen extracts and recombinant allergen programs.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Allergopharma
AI assessmentNot HiringNo open roles listed right now. Follow Allergopharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
15 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Noninterventional Study on Tolerability and Safety of One Strength Updosing With Novo-Helisen Depot
Allergic Rhinitis Due to House Dust MiteClinical Trials (1)
NCT07096440Noninterventional Study on Tolerability and Safety of One Strength Updosing With Novo-Helisen Depot House Dust Mites
N/AHelp build intelligence for Allergopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.